IMCD N.V.
IMCD N.V. (IMDZF) Financial Performance & Income Statement Overview
Explore the financials of IMCD N.V. (IMDZF), including yearly and quarterly data on income, cash flow, and balance sheets.
IMCD N.V. (IMDZF) Income Statement & Financial Overview
View the income breakdown for IMCD N.V. IMDZF across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $2.34B | $2.39B | $2.16B | $1.08B |
| Cost of Revenue | $2.09B | $1.78B | $1.92B | $807.72M |
| Gross Profit | $257.40M | $615.64M | $232.11M | $274.70M |
| Gross Profit Ratio | $0.11 | $0.26 | $0.11 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $56.61M | $268.97M | $59.15M | $123.62M |
| Operating Expenses | $46.21M | $395.52M | $42.60M | $165.60M |
| Total Costs & Expenses | -$2.13B | $2.17B | $1.97B | $973.32M |
| Interest Income | $2.56M | $3.10M | $33.40M | $14.14M |
| Interest Expense | $37.05M | $0.00 | $29.32M | $0.00 |
| Depreciation & Amortization | $69.73M | $66.87M | $60.37M | $17.33M |
| EBITDA | $293.34M | $287.55M | $114.43M | $114.43M |
| EBITDA Ratio | $0.13 | $0.12 | $0.12 | $0.11 |
| Operating Income | $211.19M | $220.13M | $189.50M | $97.10M |
| Operating Income Ratio | $0.09 | $0.09 | $0.09 | $0.09 |
| Other Income/Expenses (Net) | -$24.64M | -$26.70M | -$94.54M | -$2.14M |
| Income Before Tax | $186.55M | $193.43M | $189.89M | $94.96M |
| Income Before Tax Ratio | $0.08 | $0.08 | $0.09 | $0.09 |
| Income Tax Expense | $49.59M | $52.18M | $50.37M | $25.18M |
| Net Income | $136.98M | $141.26M | $139.58M | $69.79M |
| Net Income Ratio | $0.06 | $0.06 | $0.06 | $0.06 |
| EPS | $2.38 | $2.48 | $2.45 | $1.22 |
| Diluted EPS | $2.38 | $2.48 | $2.45 | $1.22 |
| Weighted Avg Shares Outstanding | $57.49M | $56.95M | $56.92M | $57.03M |
| Weighted Avg Shares Outstanding (Diluted) | $57.60M | $56.95M | $57.08M | $57.08M |
Financial performance has remained strong, with revenue growing from $1.08B in Q3 2023 to $2.34B in Q4 2024. Gross profit continued to perform well, with margins at 11% in the latest quarter. Operating income reached $211.19M in Q4 2024, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $293.34M. Net income dropped to $136.98M, keeping EPS at $2.38. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan